fda glp-1 warning news september 2025 The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw Novo Hit With FDA Warning

GSH catabolism alters drug sensitivity The metabolic environment can influence the sensitivity of cancer cells to anticancer compounds 41,42

Although these preclinical findings are promising for muscle quality, they need to be confirmed in clinical studies, as human data remain scarce

This interaction activates intracellular signaling pathways associated with growth hormone (GH) release [1] [2]

Regular monitoring and surveillance identify and treat potential recurring polyps after polyp excision

Addepalli V, Suryavanshi SV (2018) Catechin attenuates diabetic autonomic neuropathy in streptozotocin induced diabetic rats